{"prompt": "['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'Non-Interventional Study Adverse Event Report Form', 'For Protocols without Stipulated Active Collection of Adverse', 'For Pfizer internal use only', 'Events (Including Pragmatic Clinical Studies [Non-Medicinal Intervention])', 'AER # (insert when known)', 'Case #', 'Date Reported to Pfizer', 'Pfizer', '-', '-', 'PROTOCOL #', 'SUBJECT #', 'Relevant Tests', 'List only relevant confirmatory and diagnostic test results for event(s), for example, from blood tests, diagnostic imaging,', 'None', 'etc. If more space is needed, use additional copies of this page', 'Unknown', 'Test', 'Date', 'Result', 'Units', 'Normal Range', 'Comments', 'Low', 'High', '-', '-', 'DD-MMM-YYYY', '-', 'DD-MMM-YYYY', 'DD-MMM-YYYY', '-', 'DD-MMM-YYYY', 'Event Narrative', 'Provide clear narrative description of the sequence of event(s), diagnosis, treatment, and any other relevant details. If more space is needed,', 'use additional copies of this page.', 'Version 2.0, Effective August 2016', 'Page', 'of', 'Pfizer Confidential', 'Page 61 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'Non-Interventional Study Adverse Event Report Form', 'For Protocols without Stipulated Active Collection of Adverse', 'For Pfizer internal use only', 'Events (Including Pragmatic Clinical Studies [Non-Medicinal Intervention])', 'AER # (insert when known)', 'Case #', 'Date Reported to Pfizer', 'Pfizer', '-', '-', 'PROTOCOL #', 'SUBJECT #', 'Reported By: (PRINT)', 'Healthcare Professional?', 'Yes', 'No', 'Unknown', 'Last Name', 'First Name', 'Address:', 'City:', 'Postal Code:', 'Telephone:', 'State/Province:', 'Country:', 'Fax:', 'Date:', 'Email Address:', 'DD-MMM-YYYY', 'Check if reporter grants permission to be contacted by the Company for additional information if needed.', 'Reporter Occupation:', 'Physician', 'Pharmacist', 'Nurse', 'Other Healthcare Professional', 'Consumer\\\\Other Non-HCP', 'Lawyer', \"Name of Patient's Prescribing/Primary Physician (if known, PRINT):\", 'Last Name', 'First Name', 'Address:', 'City:', 'Postal Code:', 'Telephone:', 'State/Province:', 'Country:', 'Email Address:', 'Check if reporter grants permission to contact his/her physician for additional information if needed.', 'Prepared By: (PRINT)', 'Last Name', 'First Name', 'Vendor/', 'Program', 'Telephone:', 'City:', 'Country:', 'Staff', 'Comments:', 'Version 2.0, Effective August 2016', 'Page', 'of', 'Pfizer Confidential', 'Page 62 of 64']['Tofacitinib', 'A3921284 NON-INTERVENTIONAL STUDY PROTOCOL', 'Amended, 12-December-2018', 'ANNEX 8. NIS AEM Report Form 3 (Pregnancy)', 'Exposure During Pregnancy (EDP) Supplemental Form', 'For Pfizer internal use only', 'AER # (insert when known)', 'Local #', 'Date Reported to Pfizer', 'Pfizer', 'Il', 'Il', 'Il', '[1', '11', 'Il', 'PROTOCOL #', 'SUBJECT #', 'Complete whenever an embryo or fetus has been exposed to study drug. Send as soon as EDP has been diagnosed, together', 'with the SAE Report Form with the appropriate fields completed. If more space is needed, use additional copies of this page.', 'Pregnancy', 'First Day of Last Menstrual Period', 'Estimated Date of Conception', 'H', 'DD-MMM-YYYY', 'DD-MMM-YYYY', 'Gestation at time', 'of initial exposure', 'weeks Or, if number of weeks unknown:', 'First trimester?', 'Second trimester?', 'Third trimester?', 'Relevant History/Exposure to Products', 'Risk factors for adverse pregnancy outcomes including environmental or occupational exposures, e.g. hypertension, diabetes, etc. Family', 'history of congenital abnormality/genetic diseases, consanguinity (or any family relation or lineage) between parents (specify degree):', '1) Did the mother smoke during this pregnancy?', 'No', 'Yes: Number per day?', '2) Did the mother drink alcohol during this pregnancy?', 'No', 'Yes Frequency?', '3) Did the mother use illicit drugs during this pregnancy?', 'No', 'Yes Frequency?', 'Obstetrical History (Check the box if not applicable)', 'Not Applicable: No previous pregnancy', 'Number of previous pregnancies', 'Number of other children', 'Outcome of previous pregnancies (live birth, miscarriage, elective termination, late fetal death, ectopic pregnancy, molar pregnancy).', 'Previous maternal pregnancy complications. Previous fetal/neonatal abnormalities and type. History of sub-fertility.', 'OUTCOME OF PREGNANCY', 'Complete and send after the end of pregnancy in all cases when an embryo or fetus has been exposed to study drug', 'Date of outcome of pregnancy', 'DD-MMM-YYYY', 'Pregnancy outcome', 'Check one', 'Full term live birth', 'Preterm live birth', 'Stillbirth*', 'Spontaneous abortion/miscarriage*', 'Induced abortion', 'Unknown', 'Gestational age at birth in weeks, (if known):', '*Complete also the Serious Adverse Event section of the report', 'Infant', 'Check one', 'Normal', 'Congenital Malformation/Anomaly**', 'Other neonatal problem**', 'Unknown', 'Other neonatal problem/abnormality (include dysmaturity, neonatal illness, hospitalization, drug therapies) Specify:', 'Apgar Score 1min', '5min', 'Male', 'Female', 'Birthweight', 'grams Or, if birthweight in grams unknown: Birthweight', 'lb', 'OZ', 'Length at birth:', 'in', 'cm', 'Head Circumference at birth:', 'in', 'cm', '**Complete also the Serious Adverse Event section of the report, specifying the diagnosis as the Serious Adverse Event', 'Version 7.0, Effective August 2016', 'Page', 'of', 'Pfizer Confidential', 'Page 63 of 64']\n\n###\n\n", "completion": "END"}